ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,371Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 130

$531K Total Retail Price of All Prescriptions

Rank: 3 out of 130

368 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

5% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 4,114 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $73 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 193 144 1 2
LEVOTHYROXINE SODIUM 176 131 2 4
OMEPRAZOLE 164 79 3 6
POTASSIUM CHLORIDE 145 111 4 30
FUROSEMIDE 144 119 5 7
AMLODIPINE BESYLATE 136 104 6 3
LISINOPRIL 129 52 7 1
PRAVASTATIN SODIUM 121 85 8 11
METOPROLOL TARTRATE 118 83 9 10
METFORMIN HCL 108 71 10 5
OXYCODONE HCL 102 38 S2 11 8
ATORVASTATIN CALCIUM 97 59 12 15
CRESTOR 90 63 13 33
METFORMIN HCL ER 89 60 14 35
METOPROLOL SUCCINATE 84 68 15 13
GABAPENTIN 80 38 16 14
CLOPIDOGREL 80 63 16 34
NEXIUM 78 62 18 84
ZOLPIDEM TARTRATE 76 52 19 25
CARVEDILOL 71 53 20 29
ALLOPURINOL 70 52 21 71
GLIPIZIDE 68 61 22 47
PROAIR HFA 68 38 22 51
TRAMADOL HCL 62 39 24 18
CYMBALTA 59 40 25 128
ATENOLOL 59 28 25 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 43 27 26
LOSARTAN-HYDROCHLOROTHIAZIDE 57 48 27 96
DIOVAN 57 37 27 40
ZETIA 55 22 30 92
LOSARTAN POTASSIUM 54 26 31 21
LANTUS SOLOSTAR 54 38 31 39
HYDROCHLOROTHIAZIDE 53 38 33 9
PANTOPRAZOLE SODIUM 52 36 34 46
PLAVIX 50 38 35 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.